Summary: Thrombolytic therapy of acute ischemic stroke can be successful only as long as there is penumbral tissue perfused at rates between the thresholds of normal function and irrevers ible structural damage, respectively. To determine the propor tion of tissue at risk of infarction, cerebral perfusion was stud ied in 12 patients with acute ischemic stroke who underwent treatment with systemic recombinant tissue plasminogen acti vator (0.9 mg/kg body weight according to National Institute of Neurological Disorders and Stroke protocol) within 3 hours of onset of symptoms, using [ ls Ol-H20 positron emission tomog raphy (PET) before or during, and repeatedly after thromboly sis. The size of the regions of critically hypoperfused gray matter were identified on the initial PET scans, and changes of perfusion in those areas were related to the clinical course (followed by the National Institutes of Health stroke scale) and to the volume of infarcted gray matter demarcated on magnetic resonance imaging 3 weeks after the stroke. Whereas the initial clinical score was unrelated to the size of the ischemic area, after 3 weeks there was a strong correlation between clinical deficit and volume size of infarcted gray matter (Spearman's rho, 0.96; P < 0.001). All patients with a severely hypoperTherapeutic strategies in acute ischemic stroke are tar geted at rescuing from infarction ischemic but potentially viable tissue, the "ischemic penumbra" (Astrup et aI., 1981; Heiss and Graf, 1994; Hossmann, 1994) . Penum bral tissue is perfused at some level between the thresh-fused « 12 mLiIOO g/min) gray matter region measuring less than 15 mL on first PET showed full morphologic and clinical recovery (n = 5), whereas those with ischemic areas larger than 20 mL developed infarction and experienced persistent neurologic deficits of varying degree. Infarct sizes, however, were smaller than expected from previous correlative PET and morphologic studies of patients with acute stroke: only 22.7% of the gray matter initially perfused at rates below the conven tional threshold of critical ischemia became necrotic. Actually, the percentage of initially ischemic voxels that became reper fused at almost normal levels clearly predicted the degree of clinical improvement achieved within 3 weeks. These sequen tial blood flow PET studies demonstrate that critically hypoper fused tissue can be preserved by early reperfusion, perhaps related to thrombolytic therapy. The results correspond with experimental findings demonstrating the prevention of large infarcts by early reperfusion to misery perfused but viable tis sue. Key Words: Acute ischemic stroke-Therapeutic effi cacy-Thrombolysis-Recombinant tissue plasminogen acti vator-Critical cerebral ischemia-Penumbra-Reperfusion IS0xygen-labelled water positron emission tomography.
olds of maintained function and preserved morphology, respectively (Astrup et aI., 1981) . As long as the duration of ischemia does not exceed a certain time window, tis sue damage may be reversible (Heiss and Rosner, 1983) . Therefore, the ischemic penumbra is a dynamic process of impaired perfusion and relatively preserved metabo lism at an unstable level: there is potential for recovery, but also for progressive, selective necrosis or regional infarction. In patients with acute ischemic stroke, posi tron emission tomography (PET) studies identify an ab normality termed misery perfusion (Baron et aI., 1981) , which is characterized by an increase in regional oxygen extraction fraction caused by a severe decrease in CBP and a lesser decrease in the respective cerebral metabolic rate for oxygen.
Systemic thrombolytic therapy was shown to be clini cally effective when initiated shortly after onset of clini cal signs of cerebral ischemia (National Institute of Neu rological Disorders and Stroke [NINDS] 1995, European Cooperative Acute Stroke Study: Hacke et aI., 1995) . However, evidence has been scarce that thrombolytic treatment of patients actually salvages tissue character ized by dense initial ischemia. This lack of physiologic evidence largely results from the fact that acute thera peutic interventions do not permit time-consuming stud ies of energy metabolism and CBF. Moreover, placement of arterial lines for blood sampling, as required for ab solute quantitation, is contraindicated. In this study, the blood flow of severely hypoperfused cerebral gray mat ter eventually undergoing infarction or maintaining mor phologic integrity was assessed in 12 patients with acute ischemic stroke, using PET at the time of systemic thrombolytic therapy and again approximately 3 and 24 hours later. Since quantitative measures of CBF could not be obtained at this acute stage, relative regional tracer uptake was used to estimate the level of residual blood flow in the affected hemisphere. The clinical defi cit and the observed patterns of early flow change then were related to the infarcts detected on anatomically matched magnetic resonance imaging (MRI) scans ob tained approximately 3 weeks after the ictus, and to the clinical outcome at that time.
METHODS

Patient selection and management
Between March 1996 and October 1997, 15 patients with acute hemispheric stroke were admitted to the Neurological Hospital of the University of Cologne, Germany, during oper ating hours of the PET unit. The onset of their neurologic symptoms was verified to have occurred less than 180 minutes before treatment was begun. The other inclusion and exclusion criteria were adopted from the NINDS study and extended by the following ECASS exclusion criteria: age older than 80 years, hypodensity covering more than one third of the middle cerebral artery territory on initial computed tomography (CT) scans, severely impaired consciousness, or forced head and eye deviation (Hacke et al. 1995) . After informed consent had been obtained from the patients or their next of kin, after explanation of the benefits and hazards of the intended treatment and of the diagnostic procedures including PET, systemic thrombolytic treatment was performed according to a protocol similar to the one of the NINDS study (NINDS, 1995) , using 0.9 mg of recombinant tissue plasminogen activator (rt-PA) per kg body weight (Altepease, Thomae, Biberach, Germany: 10% of total dose by intravenous bolus injection, 90% by intravenous infu sion over 1 hour). This was immediately followed by a medical regimen including intravenous heparin administered first as a bolus of 5000 IV and continued at a dosage maintaining plasma partial thromboplastin time at a level between one and a half and two times the normal value for 10 days. The CT scanning was repeated routinely at 24 hours and when any neurologic deterioration occurred. During the first 3 to 5 days after the stroke, the patients were monitored in the neurologic intensive care unit, where blood pressure was medically controlled between 140/90 and 160/100 mm Hg. In four patients, medical therapy to control blood pressure was necessary during their hospital stay. Three of them received nifedipine in the acute phase, one urapidil. On days 2 to 4, these patients were put on definite antihypertensive treatment (angiotensin convert ing enzyme inhibitors, diuretics, f3-blockers).
Sequence of positron emission tomography and imaging studies
Recombinant tissue plasminogen activator was administered while the patient was positioned in the PET scanner. The first CBF study (taking 2 minutes) was performed right before or during the first 10 minutes of rt-PA infusion. The CBF was reassessed approximately 2 hours and again 18 to 28 hours after the end of that infusion. Three weeks later, the size and location of the final infarct were determined on T I-weighted MRI scans acquired simultaneously as 64 transaxial, 2.5-mm thick slices using a 1.0 T Magnetom impact scanner (Siemens, Erlangen, Germany) and a three-dimensional sequence.
Positron emission tomography procedures and image analysis
The PET studies were performed on an ECAT EXACT HR scanner (Siemens/CT!, Knoxville, TN, U.S.A.) in three dimensional data acquisition mode providing 47 contiguous 3-mm slices at 5 mm full width at half maximum in-plane reconstructed resolution (Wienhard et aI., 1994) . Cerebral blood flow was measured according to the eSOl-H20 intrave nous bolus method (Herscovitch et aI., 1983) using 60 mCi for each study. However, since arterial blood samples could not be obtained because of the thrombolytic treatment, regional tracer uptake was determined voxel by voxel in gray matter structures of the affected hemisphere, and the respective ratio to the mean of the contralateral hemisphere, expressed as a percentage, was used as relative measure of perfusion.
Using an interactive program (Pietrzyk et aI., 1994) , the r150j-H20 PET images were coregistered to the individual MRI volume along the anterior commisure-posterior commi sure line, and gray matter regions were defined by individually thresholding the MRI data of the affected hemisphere. The cerebral hemispheres, gray matter infarct, and noninfarcted gray matter then were segmented from the MRI volumes by means of Interactive Data Language (Research Systems, Inc., Boulder, CO, U.S.A.) and C-based image analysis system op erating at a spatial resolution of I mm3 (von Stockhausen et aI., 1996) .
Data analysis
Clinical scores. The National Institutes of Health Stroke Scale (NIHSS) (Lyden et aI., 1994) was used to quantify the neurologic deficit before thrombolytic therapy and 3 weeks later (Table I) . To assess the effect of treatment on clinical symptoms, a percentage improvement, from the initial NIHSS score to the score after 3 weeks, was calculated according to the following equation:
NIHSSini t -NIHSS 3 weeks 6NIHSS = NIHSS . X 100. lmt Therefore, patients with no change had a 6NIHSS of 0%, and those with full recovery achieved a 6NIHSS of 100%.
Definition of gray matter compartments in the affected hemi sphere. The threshold of severe hypoperfusion in gray matter was operationally set to 50% [1501-H20 uptake relative to the mean of the contralateral hemisphere. This perfusion level was chosen because in a previous quantitative CBF-PET study of * Relative to all gray matter of the affected cerebral hemisphere.
acute ischemic stroke in patients not receiving thrombolytic treatment, it had been shown to correspond to a gray matter blood flow of less than 12 mUlOO g/min (L(ittgen et ai., 1998), which represents the widely accepted viability threshold (Baron et ai., 1984; Powers et ai., 1985) . Hence, gray matter voxels showing only 50% or less uptake on first measurement were considered critically hypoperfused, whereas gray matter initially exhibiting uptake ratios greater than 50% was regarded as hardly being threatened by infarction. That physiologic clas sification was combined with morphologic outcome (infarcted, noninfarcted) to obtain two compartments: (1) not critically ischemic and not becoming infarcted; and (2) critically hy poperfused or turning into an infarct according to MRI criteria. Only the latter compartment comprising three subcompart ments (all voxels ischemic on initial PET or infarcted on late MRI) was the target region of further analyses. Patient grouping. Three eligible patients were excluded from this study for various reasons: one because the initial ischemia demonstrated by PET was restricted to white matter only, one because of reinfarction before MRI, and one because of treat ment-related space-occupying hemorrhagic transformation of his infarct, thus avoiding ambiguities of interpretation. Because the size of an infarct is likely related to the severity and spatial extent of the causative ischemia, the remaining 12 patients (5 women, 7 men; median age 68.5 years; range 50 to 76 years) were divided into two groups according to the volume of criti cally hypoperfused gray matter on their first PET scan: group S (n = 5) exhibiting a small ischemic zone of less than 15 mL (median 10.3 mL; range 0.9 to 14.9 mL), and group L (n = 7) having ischemic areas larger than 20 mL (median 37.2 mL; range 20.5 to 155.3 mL).
Statistics. Because of small sample sizes, nonnormality of the data, and nonlinear relations, descriptive measures are re ported as median and range, or Spearman's rho. Likewise, group comparisons were performed using Wilcoxon's signed ranks test, Wilcoxon-Mann-Whitney rank sum tests, or Fried man's rank analysis of variance, as appropriate. 4.7 11.6 5.2 1.5 3.7
RESULTS
Clinical deficit and infarct size
after thrombolytic treatment, and the size of gray matter infarction demonstrated by MRI after 3 weeks. The se verity of clinical symptoms ranged from slight unilateral weakness or mild aphasia to complete hemiplegia, global aphasia, impairment of consciousness, and gaze devia tion. However, although the initial clinical deficit (me dian NIHSS, 11; range 4 to 19) was not related to the size of the perfusion deficit and therefore did not differ significantly between patient groups S and L, subsequent recovery was significantly (P < 0.005) different and re lated to the size of the initially hypoperfused tissue. All patients with an initial hypoperfused gray matter volume smaller than 15 mL achieved a ANIHSS of 100% and developed no gray matter infarct. Those with larger hy poperfused areas, by contrast (P < 0.005), had infarcts comprising 0.5% to 25.9% (median 5.2%) of all gray matter of the affected hemisphere, and their clinical re covery remained incomplete, with ANIHSS ranging from 0% to 93% (median 44%). As expected, after 3 weeks there was a close correlation (rho = 0.96, P < 0.001) between infarct size and clinical deficit (Fig. 1) .
Perfusion, infarct, and clinical course
On their first PET measurement, all patients showed marked hypoperfusion in the affected middle cerebral artery territory, as summarized in Table 2 . In group S, the critically ischemic gray matter region averaged 2.9% (range 0.4% to 4.9%) of all gray matter of the affected hemisphere. In group L, on average, 11.8% (range 6.6% to 44.7%) were perfused at rates below the threshold, but only a fraction averaging less than one fourth (range 0.8% to 68.7%) of that tissue eventually became infarct ed. Therefore, with reference to all gray matter of the affected hemisphere, only 1.7% (range 0.1 % to 20.9%) initially showed dense ischemia and became infarcted, whereas 3.2% (range 0.4% to 5.0%) turned into infarc tion, despite initial perfusion above the threshold of criti cal ischemia (Table I ). In contrast to that relative lack of spatial congruence, overall there was a significant rela- tion (rho = 0.82, P < 0.001) between the size of the initial volume of critically hypoperfused gray matter and of the resulting infarct, but more detailed graphic analy sis (Fig. 2 ) also suggested a shift away from the identity line toward larger volumes of ischemic tissue. In the initially ischemic or subsequently infarcted re gion of interest, at neither PET measurement was a sig nificant difference in mean perfusion found between eventually preserved and infarcted voxels. As illustrated in Fig. 3 , averaged across all voxels in the target region, sooner or later during the PET observation period, all patients showed significant (P < 0.000 1) reperfusion. However, its degree and spatial extent were so variable as to prohibit analysis by groups. In individual cases, blood flow at second PET was at normal levels or there even was focal hyperperfusion (Fig. 4) ; in other cases, treatment restored blood flow to only part of the previ ously ischemic region, thus reducing its size (Fig. 5) . Therefore, 1 day after the ictus, in all patients, an average of 93.4% of all voxels in the target region were reper fused at levels above the critical threshold (P < 0.001), but that percentage was significantly (P < 0.025) differ ent in group S (median 100%; range 90.9% to 100%) and L (median 81.8%; range 57.0% to 100%) .
The hypothesis that early reperfusion to critically hy poperfused regions improves clinical outcome was tested by correlating the change of critically hypoperfused gray matter volume from first to third PET study (before and after thrombolysis), with the change of clinical score during the first 3 weeks after stroke (�NIHSS). That analysis revealed a significant relation (rho = 0.82; P < 0.01) between clinical course and extent of reper fusion (Fig. 6) .
The different patterns of initial hypoperfusion and fi nal infarcts can be demonstrated in individual patients, when the volumes of ischemic gray matter are coregis tered to the final MRI showing the infarct well demar cated. On reconstructed images permitting views in three planes and also from the surface of the brain, the portions of initially hypoperfused tissue eventually turning into infarction can be distinguished from morphologically preserved areas. In Case 9 (Fig. 7) , more than half of the initially hypoperfused gray matter turned into infarction and clinical outcome was poor (NIHSS after 3 weeks, 14). In Case 10 (Fig. 8) , all of the critically ischemic cortical tissue was effectively reperfused. After 3 weeks, his recovery from severe hemiparesis (initial NIHSS, 14) was complete except for a minimal facial weakness (NIHSS, I), and MRI indicated some ischemic changes only of his right putamen. 
DISCUSSION
In patients with acute ischemic stroke, CT is the first diagnostic step (Adams et aI., 1994) to rule out other pathologies such as intracranial hemorrhage, tumors, or inflammatory diseases, and early hypodensity predicting a large infarct with poor clinical outcome (von Kummer et aI., 1994 (von Kummer et aI., ,1997 Toni et al. 1995 Toni et al. , 1996 . When throm bolytic therapy is initiated within 3 hours of onset of stroke symptoms, CT cannot sharply discriminate be tween patients who will benefit or experience additional damage from this treatment. As recently pointed out (Fi eschi et aI., 1996) , imaging of abnormalities of perfusion and metabolism that precede the structural changes vis ible on early CT is better suited for the identification of ischemic tissue in early stroke, and thus also for demon stration of the effect of thrombolysis.
Functional imaging studies of early stroke have mainly used single photon emission computed tomogra phy (SPECT) to detect perfusion deficits (Alexandrov et aI., 1996) . Those studies implied a relation between early blood flow changes and long-term clinical outcome or the development of severe edema and hemorrhagic trans formation (Giubilei et aI., 1990; Hanson et aI., 1993; Overgaard et aI., 1993; Ueda et aI., 1994; Baird et aI., 1996) . Effects of acute treatment were followed only in a few cases: some of the patients, in whom reperfusion achieved by thrombolytic treatment could be demon strated, had a favorable clinical outcome (Herderschee et aI., 1991; Ezura et aI., 1996) , whereas no treatment effect on perfusion usually was associated with poor prognosis. Furthermore, severe hypoperfusion (less than 35% of contralateral reference region or of cerebellum) predicted hemorrhagic complications (Ezura et al. 1996 aI., 1994) or evolution of severe edema and tentorial herniation (Herderschee et aI., 1991) . When blood flow exceeded a critical value of 70% of the contralateral region, outcome was favorable, without development of infarction, irrespective of the degree of recanalization (Ezura et aI., 1996) .
A different perfusion range, at which recanalization achieved by intra-arterial thrombolytic treatment within 3.5 to 7.25 hours of onset of stroke can save ischemic tissue, was semiquantitatively determined by Sasaki and colleagues (1996) using [ 99 mTc]HM-PAO SPECT: reperfusion significantly reduced the likelihood of in farction in those regions where isotope uptake was de creased to values between 65% and 85% of the contra lateral side, whereas it was without effect in areas with lower uptake before treatment. Regions with higher re sidual perfusion recovered, irrespective of the success of recanalization. Grotta and Alexandrov (1998) recently reported on the effect of rt-PA on blood flow determined by HMP AO-SPECT in a small cohort selected from the NINDS study. In this controlled study, significantly greater reperfusion occurred in the rt-PA-treated than in the placebo group. All of the SPECT studies used a re gion-of-interest analysis, but coregistration of early per fusion to late morphologic images was not attempted. Therefore, the volumes of brain tissue rescued by reper fusion could not be determined. It was also beyond the scope of those studies to assess the extent of reperfusion after efficacious thrombolysis as opposed to treatment failures.
Special MRI techniques capable of detecting critically hypoperfused tissue from the differences between perfu sion and diffusion-weighted images (Warach et aI., 1992 (Warach et aI., , 1995 Welch et aI., 1995) from irreversible ischemic injury (Hasegawa et aI., 1994) , but they await broader clinical application (Warach et aI., 1997) . Therefore, PET continues to be the only validated functional imaging modality permitting visualization of irreversibly damaged tissue in early isch emia (Baron et aI., 1984; Powers et aI., 1985) that also is able to detect viable but misery perfused tissue that can be followed over time (Wise et al., \983; Hakim et aI., 1989; Heiss et aI., 1992) . The latter penumbral tissue was repeatedly shown to not necessarily turn into infarction, but to recover function and maintain morphologic integ rity in some cases (Heiss et aI., 1993; Furlan et aI., 1996) . Quantitative, multitracer PET studies, therefore, appear ideal to prove the efficacy of therapeutic strategies in tended to protect tissue threatened by ischemia. How ever, their application is limited by complex logistics, thus preventing around-the-clock service. Moreover, they require lengthy procedures that are not commensu rate with acute interventional treatment, and conven tional quantitation requires arterial blood sampling that is contraindicated in systemic thrombolysis. Therefore, minimally invasive procedures are needed that can be executed rapidly, without interference with therapeutic regimens. The [ 15 0l-H20 bolus injection PET method (Herscovitch et a!., 1983 ) comes closest to those require ments, when perfusion is assessed semiquantitatively us ing relative tracer uptake values. From the latter data, the flow values in ischemic gray matter could be estimated in our study by reference to a calibration curve obtained from quantitative CBF measurements in a distinct group of patients with acute ischemic stroke who did not re ceive thrombolytic therapy (Lottgen et aI., 1998) . That way, critical hypoperfusion could be operationally de fined: tracer uptake of 50% of the mean of the contra lateral hemisphere was equivalent to 8 to 12 mUlOO g/min and represented CBF at the viability threshold of gray matter (Baron et aI., 1984; Powers et aI., 1985) . This procedure allowed the assessment of perfusion before thrombolytic therapy within 3 hours of onset of stroke, thus making possible the study of tissue compartments selected on grounds of their residual flow and finally infarcted or preserved gray matter structures. The results clearly demonstrate that clinical outcome and infarct size are correlated. Both depend on the initial spatial extent rather than the depth of critical ischemia and also on the proportion of gray matter that is effec tively reperfused. This study was not designed to yield statistically convincing proof of the efficacy of throm bolytic therapy, since only a few patients could be en tered and there is no control group. Such evidence must be derived from large, controlled, multicenter trials (NINDS, 1995; Hacke et a!., 1995) . Our study, however, supports the results of those clinical trials and extends the recent observation of Grotta and Alexandrov (1998) by identifying the portions of compromised tissue that become reperfused and do not proceed to infarction. Re markably, although patient subgroups could not be dis tinguished by the severity of their initial clinical deficit, the size of the critically ischemic area on first PET scan was an excellent predictor of infarct size 3 weeks later and, likewise, of the neurologic deficit at the postacute stage, whereas reperfusion occurred to some portions of the hypo perfused tissue in all cases. Clearly, patients with small volumes of ischemic gray matter fared better than those with large ischemic lesions. However, con trary to the expectation derived from previous PET stud ies of the natural history of acute stroke, whereas two thirds either had no persistent morphologic damage (three in group S) or developed infarcts that were much smaller than predicted (five group L), only one third of the patients (two in group S, two group L) eventually showed either no lesion or infarcts that were almost con gruent with the initial area of severe ischemia. Since patients with small and large ischemic areas, respec tively, achieved similar levels of reperfusion of their tar get regions within I day of thrombolytic therapy, sug gesting a similar efficacy of reperfusion, both groups showed comparable improvement of their absolute clini cal scores. However, for group S patients, this meant full clinical recovery, and, therefore, their percentage change was significantly better. Conversely, the clinical im provement observed during the first 3 weeks after throm bolytic treatment was accurately predicted by the relative change in size of the critically hypoperfused area mea sured on the first day.
The design of our study does not permit conclusive recommendations as to the selection of patients who might benefit from thrombolytic therapy. Because of the semiquantitative nature of the perfusion values and the wide scatter of the time intervals between onset of symp toms and beginning of treatment or PET study, a corre lation between residual CBF and duration of ischemia, as was established in animal experiments (Heiss and Ros ner, 1983) , cannot be derived from the current results. Such a relation is further obfuscated by the varying de lays between initiation of rt-PA infusion and recanaliza tion of occluded vessels, which again differed from pa tient to patient and between different regions within an ischemic territory. Even with intra-arterial administration of thrombolytic agents, it usually takes 2 hours before all branches of an occluded artery are recanalized (Zeumer et a!., 1993) , and this time interval may be prolonged with systemic intravenous infusion (von Kummer and Hacke, 1992) . As was shown in animal experiments with transient occlusion of the middle cerebral artery (Young et a!., 1996; Heiss et a!., 1997) , small changes in residual perfusion and oxygen supply during ischemia have a significant impact on the probability of tissue survival after reperfusion and on final clinical outcome. . Case 9. The MRI brain sur face reconstruction (slightly rotated right lateral view) and superim posed target region (red, infarct; blue, initially hypoperfused at lev els below threshold of critical isch emia). Image triplets represent or thogonal T1-weighted MRI or coregistered segmented PET sec tions across the center of infarction.
ing on the level of residual flow, infarcts may grow for up to several days after vascular occlusion (Touzani et aI., 1995) . But contrary to a purely experimental setting, highly accurate measurements cannot be obtained under conditions of a clinical emergency. However, blood flow, no matter how important its level may be initially, clearly is not the only parameter predicting the ultimate fate of the tissue at some points in time after the initial FIG. 8. Case 10 (same as in Fig.   4 ). The MRI brain surface recon struction (slightly rotated right later al view) and superimposed dis tribution of cortical voxels initially hypoperfused at levels below threshold of critical ischemia (blue). Image triplets shown as in Fig. 7 . Notice the small subcortical gray matter infarction (red).
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ischemic attack. Even our data indicate some growth of infarction into initially nonischemic areas, as expressed in the portion of the final infarct that was not hypoper fused on first measurement, occurring concurrent with the shrinkage of hypoperfused areas. This reflects the complex metabolic and molecular mechanisms involved in the propagation of ischemic tissue damage continuing even after reperfusion. However, as long as quantitation of several variables is not feasible with the required pre cision, CBF measurements at defined points in time after acute stroke can be helpful in selecting patients who will benefit from thrombolytic therapy and for excluding those in whom thrombolysis is likely to be ineffective or dangerous. In stroke victims for whom thrombolytic treatment is not recommended (Quality Standards Sub committee, 1996) , the assessment and follow-up of ini tially hypoperfused and ischemically compromised tis sue can be helpful in the evaluation of ancillary or alter native regimens of neuroprotection (Dorman et aI., 1996) that may restrict the size of final infarcts by using ex tended therapeutic windows (Baron et ai. 1995) and thus improving clinical outcome.
